In November, the Company was listed on the National Equities transfer System for Small and Medium-sized Enterprises. Its stock abbreviation is Hongyuan Pharmaceutical, with the stock code of 831265.
The Company carried out shareholding reform and changed the name of “Hubei Hongyuan Pharmaceutical Co., Ltd.” to “Hubei Hongyuan Pharmaceutical Technology Co., Ltd.”.
The Company introduced strategic investor Mr. Yan Xiaohui to become the Company's principal shareholder.
It changed the name of “Luotian County Hongyuan Chemical API Co., Ltd.” to “Hubei Hongyuan Pharmaceutical Co., Ltd.”.
Hubei Hengri Chemical General Factory and Hubei Hengri Chemical Co., Ltd. declared bankruptcy, and Hongyuan Company bought out all the assets of the above-mentioned bankrupt enterprises through legal procedures.